NantHealth NH
$ 1.35
-46.64%
Quarterly report 2023-Q3
added 11-22-2023
NantHealth Balance Sheet 2011-2024 | NH
Annual Balance Sheet NantHealth
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
4.4 M | -20.9 M | -22.5 M | 201 M | 182 M | 134 M | 30.7 M | -5.99 M | 30.8 M | - | - | - |
Long Term Debt |
4.05 M | 6.25 M | - | 206 M | 200 M | 195 M | 191 M | - | - | - | - | - |
Long Term Debt Current |
2.1 M | 1.91 M | 1.9 M | 1.92 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 266 M | 247 M | 220 M | 215 M | 184 M | 159 M | - | - | - |
Total Current Liabilities |
35.6 M | 27.9 M | 125 M | 57.5 M | 36.5 M | 35.9 M | 57.2 M | - | - | - | - | - |
Total Liabilities |
385 M | 360 M | 312 M | 324 M | 284 M | 256 M | 273 M | 227 M | 246 M | - | - | - |
Deferred Revenue |
2.72 M | 2.44 M | 1.17 M | 16.7 M | 16.3 M | 10.1 M | 17.2 M | 10.7 M | 24.1 M | - | - | - |
Retained Earnings |
-1.12 B | -1.05 B | - | -947 M | -884 M | -693 M | -475 M | -291 M | -219 M | - | - | - |
Total Assets |
160 M | 198 M | 190 M | 266 M | 286 M | 449 M | 684 M | 412 M | 311 M | - | - | - |
Cash and Cash Equivalents |
1.76 M | 29.1 M | 22.8 M | 5.24 M | 18.3 M | 61.7 M | 160 M | 5.99 M | - | - | - | - |
Book Value |
-225 M | -162 M | -122 M | -57.1 M | 2.83 M | 193 M | 412 M | 185 M | 64.8 M | - | - | - |
Total Shareholders Equity |
-225 M | -162 M | -112 M | -57.1 M | 2.83 M | 193 M | 412 M | 185 M | 64.8 M | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet NantHealth
2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
2.18 M | 3.32 M | 4.05 M | 4.55 M | - | 5.71 M | 6.25 M | 6.88 M | 7.26 M | 7.72 M | 8.17 M | 8.17 M | 8.17 M | 8.17 M | 9.73 M | 9.73 M | 9.73 M | 9.73 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
397 M | 406 M | 385 M | 362 M | - | 358 M | 360 M | 364 M | 361 M | 320 M | 312 M | 312 M | 312 M | 312 M | 324 M | 324 M | 324 M | 324 M | 284 M | 284 M | 284 M | 284 M | 256 M | 256 M | 256 M | 256 M | 273 M | 273 M | 273 M | 273 M | 60.9 M | 60.9 M | 60.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
2.14 M | 3.41 M | 2.72 M | 2.66 M | - | 2.7 M | 2.44 M | 1.94 M | 1.25 M | 1.22 M | 1.17 M | 1.17 M | 1.17 M | 1.17 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 16.3 M | 16.3 M | 16.3 M | 13.1 M | 10.1 M | 9.2 M | 18.7 M | 16.5 M | 9.6 M | 9.6 M | 17.2 M | 17.2 M | 10.7 M | 10.7 M | 10.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.17 B | -1.13 B | -1.12 B | -1.1 B | - | -1.07 B | -1.05 B | -1.04 B | -1.03 B | -1.01 B | -1 B | -1 B | -1 B | -1 B | -947 M | -947 M | -947 M | -947 M | -884 M | -884 M | -884 M | -884 M | -693 M | -693 M | -693 M | -693 M | -475 M | -475 M | -475 M | -475 M | -291 M | -291 M | -291 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
146 M | 170 M | 160 M | 161 M | - | 181 M | 198 M | 217 M | 225 M | 188 M | 200 M | 200 M | 200 M | 200 M | 266 M | 266 M | 266 M | 266 M | 286 M | 286 M | 286 M | 286 M | 449 M | 449 M | 449 M | 449 M | 684 M | 684 M | 684 M | 684 M | 412 M | 412 M | 412 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
5.82 M | 14.1 M | 1.76 M | 2.44 M | - | 18.3 M | 29.1 M | 47.8 M | 52 M | 10.8 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M | 5.24 M | 5.24 M | 5.24 M | 5.24 M | 18.3 M | 18.3 M | 18.3 M | 18.3 M | 61.7 M | 61.7 M | 61.7 M | 61.7 M | 158 M | 158 M | 160 M | 160 M | 5.99 M | 5.99 M | 5.99 M | - | 3.7 M | - | - | - | 17 M | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
-250 M | -237 M | -225 M | -201 M | - | -177 M | -162 M | -147 M | -136 M | -132 M | -111 M | -111 M | -111 M | -111 M | -57.1 M | -57.1 M | -57.1 M | -57.1 M | 2.83 M | 2.83 M | 2.83 M | 2.83 M | 193 M | 193 M | 193 M | 193 M | 412 M | 412 M | 412 M | 412 M | 351 M | 351 M | 351 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-250 M | -237 M | -225 M | -201 M | -188 M | -177 M | -162 M | -147 M | -136 M | -132 M | -112 M | -112 M | -112 M | -112 M | -57.1 M | -57.1 M | -57.1 M | -57.1 M | 2.83 M | 2.83 M | 2.83 M | 2.83 M | 193 M | 193 M | 193 M | 193 M | 412 M | 412 M | 412 M | 412 M | 185 M | 185 M | 185 M | - | 64.8 M | - | - | - | 20.7 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency